BTIG analyst Gregory Lewis upgrades Borr Drilling (NYSE:BORR) from Neutral to Buy.
Where OptimizeRx Stands With Analysts
Throughout the last three months, 4 analysts have evaluated OptimizeRx (NASDAQ:OPRX), offering a diverse set of opinions from…